Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 1;111(1):1508-1512.
doi: 10.1097/JS9.0000000000001987.

Five decades of clinical ABO-incompatible liver transplantation research: a bibliometric analysis

Affiliations

Five decades of clinical ABO-incompatible liver transplantation research: a bibliometric analysis

Maiwulanjiang Maimaiti et al. Int J Surg. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Figures

Figure 1
Figure 1
(A) The flowchart illustrates the study design and analysis approach used in the present study. (B) The chart shows the number of publications from 1973 to 2023. (C,D) Geographical distributions and network analysis of the 200 articles from 1973 to 2023.
Figure 2
Figure 2
(A) A network map showing authors. (B) The journals of articles published from 1973 to 2023, and the size of circle represent the number of articles published, the more articles are published the circle’s color gradually approaches the red. (C) A network map of keywords. (D) Top 25 keywords with strongest citation burst.

References

    1. Egawa H, Oike F, Buhler L, et al. . Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004;77:403–411. - PubMed
    1. Yamamoto H, Uchida K, Kawabata S, et al. . Feasibility of monotherapy by rituximab without additional desensitization in ABO-incompatible living-donor liver transplantation. Transplantation 2018;102:97–104. - PubMed
    1. Piro LD, White CA, Grillo-López AJ, et al. . Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin’s lymphoma. Ann Oncol 1999;10:655–661. - PubMed
    1. Monteiro I, McLoughlin LM, Fisher A, et al. . Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation. Transplantation 2003;76:1648–1649. - PubMed
    1. Song GW, Lee SG, Hwang S, et al. . ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab. Am J Transplant 2016;16:157–170. - PubMed

LinkOut - more resources